Sunday, February 8, 2026

Hims & Hers abandons copycat weight-loss drug in face of FDA probe

Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy

from News Feed https://ift.tt/ERTq9Fk
via IFTTT
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)